Correlation Between Bristol Myers and SP 500

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and SP 500 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and SP 500 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and SP 500 Financials, you can compare the effects of market volatilities on Bristol Myers and SP 500 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of SP 500. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and SP 500.

Diversification Opportunities for Bristol Myers and SP 500

0.88

Correlation Coefficient

Bristol Myers  SP 500

Very poor diversification

The 3 months correlation between Bristol and SPSY is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and SP 500 Financials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SP 500 Financials and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with SP 500. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SP 500 Financials has no effect on the direction of Bristol Myers i.e., Bristol Myers and SP 500 go up and down completely randomly.

Pair Corralation between Bristol Myers and SP 500

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 3.08 times more return on investment than SP 500. However, Bristol Myers is 3.08 times more volatile than SP 500 Financials. It trades about 0.16 of its potential returns per unit of risk. SP 500 Financials is currently generating about 0.09 per unit of risk. If you would invest  73,550  in Bristol Myers Squibb on September 21, 2024 and sell it today you would earn a total of  26,339  from holding Bristol Myers Squibb or generate 35.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	96.88%
Values	Daily Returns

Bristol Myers Squibb  vs.  SP 500 Financials

Pair Trading with Bristol Myers and SP 500

The main advantage of trading using opposite Bristol Myers and SP 500 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, SP 500 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SP 500 will offset losses from the drop in SP 500's long position.

The idea behind Bristol Myers Squibb and SP 500 Financials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.